Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 5;11(3):835.
doi: 10.3390/jcm11030835.

Telemedicine for the Diagnosis and Management of Age-Related Macular Degeneration: A Review

Grayson W Armstrong  1 , John B Miller  1   2
Affiliations
Review

Telemedicine for the Diagnosis and Management of Age-Related Macular Degeneration: A Review

Grayson W Armstrong et al. J Clin Med. .

Abstract

Use of ophthalmic telemedicine for patients with age-related macular degeneration (AMD) has shown remarkable advances over recent years. The recent COVID pandemic accelerated this transition since in-person evaluation of elderly patients at high risk for advanced AMD and severe vision loss were also at higher risk for complications from COVID infection. To date, ophthalmic telemedicine has been successfully used in remote retinal consultation by general ophthalmologists for AMD management, hybrid testing visits with both in-office testing and remote evaluation, as well as early successes in home-based remote monitoring of patients with high-risk AMD. We therefore review the current literature and evidence base related to ophthalmic telemedicine for AMD.

Keywords: age-related macular degeneration; ophthalmology; telemedicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Munoz B., West S.K., Rubin G.S., Schein O.D., Quigley H.A., Bressler S.B., Bandeen-Roche K., SEE Study Team Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2020;118:819–825. doi: 10.1001/archopht.118.6.819. - DOI - PubMed
    1. Wong W.L., Su X., Li X., Cheung C.M.G., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health. 2014;2:e106–e116. doi: 10.1016/S2214-109X(13)70145-1. - DOI - PubMed
    1. Chee Y., Chiang A., Houston S.K.S., 3rd, Miller J.B., Papakostas T., Ryan E.D. Covid-19 roundtable: How retina doctors from around the United States are adjusting their clinics. [(accessed on 31 December 2021)];Retin. Today. 2020 Available online: https://retinatoday.com/articles/2020-apr/covid-19-roundtable-how-retina....
    1. Borrelli E., Grosso D., Vella G., Sacconi R., Querques L., Zucchiatti I., Prascina F., Bandello F., Querques G. Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: Let’s be ready for a plausible “rebound effect”. Graefes Arch. Clin. Exp. Ophthalmol. 2020;258:2655–2660. doi: 10.1007/s00417-020-04858-7. - DOI - PMC - PubMed
    1. Wasser L.M., Weill Y., Brosh K., Magal I., Potter M., Strassman I., Gelman E., Koslowsky M., Zadok D., Hanhart J. The Impact of COVID-19 on Intravitreal Injection Compliance. SN Compr. Clin. Med. 2020;2:2546–2549. doi: 10.1007/s42399-020-00614-4. - DOI - PMC - PubMed

LinkOut - more resources